A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 384,124 shares of PFE stock, worth $11.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
384,124
Previous 364,253 5.46%
Holding current value
$11.2 Million
Previous $10.1 Million 6.32%
% of portfolio
0.27%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $501,941 - $588,181
19,871 Added 5.46%
384,124 $10.7 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $763,237 - $876,440
29,480 Added 8.81%
364,253 $10.1 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $1.23 Million - $1.6 Million
-47,069 Reduced 12.33%
334,773 $9.64 Million
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $251,328 - $293,778
7,832 Added 2.09%
381,842 $12.7 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $103,447 - $119,686
2,864 Added 0.77%
374,010 $13.7 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $233,110 - $303,475
5,918 Added 1.62%
371,146 $15.1 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $367,483 - $479,709
8,802 Added 2.47%
365,228 $0
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $376,817 - $459,999
8,611 Added 2.48%
356,426 $15.6 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $85,056 - $100,850
1,828 Added 0.53%
347,815 $18.2 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $367,143 - $454,937
8,025 Added 2.37%
345,987 $17.9 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $473,816 - $702,353
11,467 Added 3.51%
337,962 $20 Million
Q3 2021

Nov 29, 2021

BUY
$39.25 - $50.42 $12.8 Million - $16.5 Million
326,495 New
326,495 $14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Badgley Phelps Wealth Managers, LLC Portfolio

Follow Badgley Phelps Wealth Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.